“A Novel Benzenesulfonylurea-Substituted Pyridazinone Derivative with Antidiabetic Effect as the Peroxisome Proliferator-activated Receptor (PPAR-γ) Agonist”, Valensi, vol. 11, no. 1, pp. 18–29, May 2025, doi: 10.15408/jkv.v11i1.42187.